Is GPATCH11 p.Arg152Gln (c.455G>A) pathogenic?

GPATCH11 p.Arg152Gln (c.455G>A) is classified Uncertain significance in GPATCH11 (ClinVar, Single submitter, 1 submitter; last evaluated 2026-04-06). AlphaMissense: likely benign (0.1987); Ultra-rare (popmax 0.0863%, mid).

How common is GPATCH11 p.Arg152Gln (c.455G>A) in the general population?

GPATCH11 p.Arg152Gln (c.455G>A) is ultra-rare (popmax 0.0863%, mid) (gnomAD).

What do computational predictors say about GPATCH11 p.Arg152Gln (c.455G>A)?

AlphaMissense predicts likely benign (score 0.1987) — an in-silico prediction, not a clinical call.

GPATCH11 p.Arg152Gln

c.455G>A · rs375363032 · VCV3101156

Uncertain significance Single submitter

Classification

Uncertain significance

ClinVar

Review

Single submitter ★☆☆☆

ClinVar · 1 submitter

AlphaMissense

likely benign

0.1987 · ACMG-weighted

gnomAD v4.1

Rare

ultra-rare (popmax 0.0863%, mid)

Missense predictors

1/3 damaging

AlphaMissense, REVEL, SaProt

Computational evidence

Protein change
AlphaMissense	0.1987	likely benign
REVEL	0.195	benign-leaning
SaProt	LLR -10.59	damaging
⇒ SaProt calls this damaging; AlphaMissense and REVEL do not.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP 9.9	GERP 1.5, phastCons 1
Regional constraint	o/e 1.07	unconstrained · MANE · 7,878 bp · p 0.23 · regional, not allelic
Overall
CADD	27.3	PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

⚠ Isoform check: AlphaMissense numbered on a different transcript (AM R174Q vs ClinVar R152Q) — verify the residue.

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.0863% Middle Eastern · 5/5,792 alleles

Filtering AF 0.05% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.045%

Overall 0.00915% 142/1,551,860 alleles · ultra-rare exomes 130/1,400,172 · genomes 12/151,688 · joint denominator

Ancestry group	Frequency	1 in
Middle Easterngrpmax	0.0863%	1,158
South Asian	0.0641%	1,560
Remaining individualsnot grpmax-eligible	0.0285%	3,505
European (non-Finnish)	0.00563%	17,755
Admixed American	0.00421%	23,738
African / African-American	0.00278%	35,977

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: GPATCH11
Protein: p.Arg152Gln
Coding: c.455G>A
MANE Select: NM_174931
dbSNP: rs375363032
Type: single nucleotide variant
Location: chr2:37092170 (GRCh38)
Gene constraint: LOEUF 1.008 · pLI <0.01 (gnomAD)
Structure: AlphaFold pLDDT 80.60

Full GPATCH11 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

GPATCH11 p.Arg152Ter Pathogenic same residue
GPATCH11 p.Ala146Ser Uncertain significance ★ ⚠ same type
GPATCH11 p.Ala36Val Uncertain significance ★ ⚠ same type
GPATCH11 p.Ala46Val Uncertain significance ★ ⚠ same type
GPATCH11 p.Asn75Lys Uncertain significance ★ ⚠ same type
GPATCH11 p.Asp10Glu Uncertain significance ★ ⚠ same type
GPATCH11 p.Asp177Gly Uncertain significance ★ ⚠ same type
GPATCH11 p.Asp208Glu Uncertain significance ★ ⚠ same type

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/gpatch11-p-arg152gln (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown